1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Special Programs for the Aging: Title III, Part B: Grants for Supportive Services and Senior Centers is sponsored by Illinois Department on Aging. This program provides federal Older Americans Act funds and State General Revenue Funds to regional Area Agencies on Aging in Illinois.
These funds support a broad array of services that enable older adults (age 60+) to remain in their homes, including access to services (transportation, case management), in-home services (personal care, homemaker assistance), and community services (legal, mental health, adult day care). It also funds multi-purpose senior centers that offer congregate meals, health screenings, and educational activities.
The grants are awarded to Area Agencies on Aging, who then make sub-grants to local service providers.
Get alerted about grants like this
Save a search for “Illinois Department on Aging” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Nonprofit organizations and local government organizations in Illinois are eligible to receive sub-grants from Area Agencies on Aging. Applicants must serve older adults (age 60+). Confirm the full requirements in the official notice before applying.
Special Programs for the Aging: Title III, Part B: Grants for Supportive Services and Senior Centers is funded by Illinois Department on Aging. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Illinois. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article